Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2021-10-07 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2021-10-07 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd. and BSE Ltd. regarding compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions enclosing a newspaper advertisement about a Postal Ballot Notice/E-voting published in newspapers and made available on the company's website. The content is primarily an announcement informing the stock exchanges about the publication of a notice related to shareholder voting procedures. There is no substantive financial data, management discussion, or detailed report content. The document is relatively short and serves to notify the regulatory bodies of the advertisement's publication, not the report or notice itself. Therefore, it fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-09-08 English
Shareholders meeting
Regulatory Filings
2021-09-07 English
Financial Result Updates
Regulatory Filings
2021-08-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated August 9, 2021, addressed to stock exchanges (BSE and NSE) regarding an upcoming earnings call scheduled for August 16, 2021. It provides details about the call timing, dial-in numbers, and contact information. There is no actual financial data or results presented in the document, only an invitation and information about the earnings call event. The document length is 2028 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. According to the rules, announcements about earnings calls without the transcript or financial results should be classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an invitation and announcement of the call, it does not qualify as a transcript. It is also not an Earnings Release (ER) because it does not contain financial highlights or results. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event.
2021-08-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled to consider and approve the unaudited financial results for the first quarter ended June 30, 2021. It references compliance with SEBI regulations regarding insider trading and trading window closure. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notification about a board meeting and the timing of financial results approval, not the financial report or earnings release itself. The document length is short (1870 characters), and it serves as an announcement rather than a report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-08-06 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.